DiaSorin LIAISON® QuantiFERON-TB Gold Plus

The world’s leading IGRA is now available on the fully-automated LIAISON XL Analyzer

LIAISON QuantiFERON-TB Gold Plus is the first and only FDA-approved, fully automated assay to aid in the diagnosis of TB infection.

  • Streamlined workflow
  • Improved capacity and turnaround time
  • Reduced non-reportable reagent usage

Trusted QuantiFERON IGRA technology, proven LIASON XL Analyzer

QFT-Plus Blood Collection Tubes

  • Advanced QuantiFERON-TB Gold Plus tube science
  • No change required to standard QuantiFERON-TB Gold Plus blood collection processes
  • Single lithium-heparin tube blood collection or direct draw to QFT-Plus Blood Collection Tubes

LIAISON XL Chemiluminescent analysis

  • Familiar LIAISON XL analyzer and reagent integral kit format
  • Fully automated testing solution
  • 46 minutes to first result
  • Analytical results fully traceable to individual tube ID

Integrated testing on the DiaSorin LIAISON XL

DiaSorin LIAISON provides specialty testing simplified by consolidating, automating and integrating specialty immunodiagnostic testing in health systems and commercial laboratories. One fully-automated family of instruments, one standard assay format, and a full specialty menu.


The QFT-Plus advantage – four tubes, one clear result

  • Single-visit testing
  • Highly accurate and reproducible
  • Convenient and objective lab-based testing
  • Innovative CD8 T cell technology, providing a more comprehensive view of the immune response to TB infection

QuantiFERON-TB Gold Plus Blood Collection Tubes by QIAGEN and LIAISON Analyzer by DiaSorin.

LIAISON® is a registered trademark of DiaSorin

Product claims may differ from country to country based on regulations and approvals. Contact your country representative for further details.

Get in touch with QIAGEN
Follow QIAGEN on: